Clinical Insights Into Advancements in Epithelial Ovarian Cancer Treatment
Pharmacy Times,
Ovarian cancer is one of the mostcommon gynecologic cancers andholds the highest mortality rateamong cancers that affect the…
Crashing cancer’s backup system – our progress so far
Noodls,
Cancer Re UK (via noodls) / Crashing cancer’s backup system – our progress so far Several different PARP inhibitors currently…
Crashing cancer’s backup system – our progress so far
Cancer Research UK,
Several different PARP inhibitors currently in clinical development. With the phrase often touted by the media, it can be…
After the Medivation Deal - A Look at The Other Late-Stage PARP Inhibitors
Bioportfolio,
Given that Medivation (MDVN) was able to fully realize the value of its PARP inhibitor into the acquisitionprice, we took a…